Evidence map›Paper›PMID 39624392›Full record

ArticlePhysics and imaging in radiation oncology2024

A commissioning protocol for portal imaging-based radiotherapy in vivo dosimetry systems.

Marco Esposito, Riccardo Baldoni, Evy Bossuyt, Sara Bresciani, Catharine H Clark, Matthew Jones, Stephen Kry, Joseph Perry, Jeroen van de Kamer, Dirk Verellen and 1 more

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marco EspositoMedical Physic, The Abdus Salam International Centre for Theoretical Physics, Trieste, Italy.
Riccardo BaldoniU.OC-Fisica Medica e alte tecnologie, AST Pesaro Urbino, Pesaro, Italy.
Evy BossuytMedical Physics, Iridium Netwerk, Antwerp, Belgium.
Sara BrescianiMedical Physics, Candiolo Cancer Institute-FPO IRCCS, Turin, Italy.
Catharine H ClarkUniversity College London, London, UK.
Matthew JonesRoyal Surrey NHS Foundation Trust,Guildford, UK.
Stephen KryThe University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Joseph PerryRoyal Surrey NHS Foundation Trust,Guildford, UK.
Jeroen van de KamerThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Dirk VerellenMedical Physics, Iridium Netwerk, Antwerp, Belgium.
Nuria JornetServei de Radiofisica i Radioprotecció, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: With the availability of commercial electronic portal imaging detector-based in vivo dosimetry (EPID-based IVD) solutions, many radiotherapy departments are adopting this technology. However, comprehensive commissioning guidance is lacking. This study aims to provide a protocol for testing the accuracy and sensitivity of EPID-based IVD systems. Material and methods: The protocol was tested across four institutions using two different systems. Accuracy was evaluated with homogeneous slab phantoms using different square regular fields, and clinical plans in a CIRS lung phantom. Multiple forward and back-projected algorithm implementations were assessed for different energies. Sensitivity analysis in the lung phantom examined responses to setup errors, anatomical variations, and delivery errors. Results: In homogeneous phantoms, over 85 % of pixels passed the 5 %/2mm gamma criteria, except for the 2x2 cm Conclusion: We successfully developed a protocol to commission EPID IDV systems. It was found that not all systems and implementations achieved satisfactory accuracy and sensitivity, emphasising the need for thorough commissioning and benchmarking.

Indexed as

DosimetryEPID“In vivo” dose measurementsQA

Identifiers

PMID39624392
PMCPMC11609462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.